Covance
Home About Covance Investor Relations News Careers Contact Us
Home > Financial Info > Press Releases
 Advanced Search
Take me to...
Find a service
Drug Development Services
Nonclinical
Clinical
Commercialization
Industries We Serve
Biotech
Environmental
Food & Dietary Supplements
Pharma
Research
Vaccines
Antibody Products Store
Volunteer for a Study
Investigators
Information Library
Animal Welfare
COVANCE TO PRESENT AT HEALTHCARE CONFERENCES
Princeton, New Jersey, March 12, 2003 — Covance Inc. (NYSE: CVD) announced that it will participate in two upcoming healthcare conferences in March 2003. Chris Kuebler, Covance's Chairman and Chief Executive Officer, will make a formal presentation at the SG Cowen 23rd Annual Health Care Conference in Boston, Massachusetts on Tuesday, March 18 at 1:15 p.m. EST. Bill Klitgaard, Covance's Chief Financial Officer, will present at the Banc of America Securities 2003 Healthcare Conference in Las Vegas, Nevada on Tuesday, March 25 at 4:15 p.m. PST.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 2002 net revenues of $883 million, global operations in 17 countries, and approximately 6,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the website in the About Covance area.
SEC Filings
Annual Reports
Quarterly Reports
Press Releases